All seven private Integrated Shield Plan (IP) insurers in Singapore are set to launch new rider products by 1 April 2026, in line with the Ministry of Health's (MOH) revised requirements. According to reporting by The Business Times, headline premium reductions are expected to be at least 30% across insurers, with Singlife indicating that some age bands could see reductions of up to 84% (please verify against each insurer's own announcement).
The important context sits behind that headline. Under the new MOH framework, new IP riders can no longer cover the minimum deductible — policyholders must pay at least S$1,500 before insurance kicks in — and the co-payment cap doubles from S$3,000 to S$6,000. In other words, part of the premium reduction reflects real efficiency, but part of it simply reflects the fact that the policyholder now carries more of the bill out of pocket in a claim.
A few operational details are worth keeping in mind. Existing rider holders are generally not forced to switch unless their rider was purchased on or after 27 November 2025. Those without a rider today, or those actively re-evaluating their coverage, can consider the new products when they launch. Insurers including Prudential, Income, Singlife, HSBC Life, Raffles Health Insurance, AIA and Great Eastern will each release specific plan and premium details around end-March or on 1 April.
From a planning standpoint, we'd frame the decision less as "cheaper premium = better outcome" and more as "what is my total exposure in a bad year?". A lower premium is genuinely useful, but only if the household's cash buffer can comfortably absorb the higher deductible and co-payment when a hospitalisation actually happens. For families where liquidity is already tight, the trade-off deserves careful thought — the savings on premium can be wiped out by a single unplanned admission if the buffer isn't there.
It's also worth noting that the shape of savings will vary. Riders that only cover up to public-hospital stays are expected to see larger percentage reductions than those extending to private-hospital care, and older policyholders may see bigger absolute-dollar savings even at similar percentage cuts, because their base premiums are higher. Coverage details — such as whether cancer drug treatments outside MOH's Cancer Drug List remain covered, and any new value-added benefits — differ meaningfully between insurers and should be compared line by line.
At StickieMonies, the questions we're helping clients work through in this window are practical: Does your current rider fall under the pre-27 November 2025 grandfathering? Is your cash buffer sized for a S$1,500 deductible plus a S$6,000 co-payment cap in the same policy year? If you have dependants or a business relying on your income, does the overall protection stack — base IP, rider, hospital cash, critical illness, disability income — still hold together after any switch? These are personal-circumstance questions and the right answer differs across households; insurance decisions carry trade-offs including cost, liquidity and non-guaranteed features, and are best worked through with a qualified financial adviser.
If you'd like a second pair of eyes on your Integrated Shield Plan and rider before the 1 April launches, we're happy to walk through it with you. The original Business Times report is linked below.